Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT02413450
- Status
- Enrolling By Invitation
Conditions
- Arrhythmogenic Cardiomyopathy (AC, ARVD/C)
- Brugada Syndrome (BrS)
- Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Dilated Cardiomyopathy (DCM)
- Early Repolarization Syndrome (ERS)
- Hypertrophic Cardiomyopathy (HCM)
- Inherited Cardiac Arrythmias
- Long QT Syndrome (LQTS)
- Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)
- Normal Control Subjects
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Study Details
Human induced pluripotent stem cells (hiPSCs) have driven a paradigm shift in the modeling of human disease; the ability to reprogram patient-specific cells holds the promise of an enhanced understanding of disease mechanisms and phenotypic variability, with applications in personalized predictive pharmacology/toxicology, cell therapy and regenerative medicine. This research will collect blood or skin biopsies from patients and healthy controls for the purpose of generating cell and tissue models of Mendelian heritable forms of heart disease focusing on cardiomyopathies, channelopathies and neuromuscular diseases. Cardiomyocytes derived from hiPSCs will provide a ready source of disease specific cells to study pathogenesis and therapeutics.
Key Dates
- Start date
- Aug 31, 2013
- Status verified
- Jan 2026
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2031
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
•Production of cardiomyocytes and engineered tissues from hiPSC-derived cardiomyocytes to be used in mechanistic studies of disease and testing of therapeutic interventions. [ Time Frame: 10 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Medical Institute | Baltimore | Maryland | 21287-9106 | - |
Find similar trials in Baltimore, MD
Related Studies
- Large Language Models To Improve the Quality of Care of Cardiology PatientsRecruiting · Stanford University · Palo Alto, California
- HCMR Re-Imaging StudyRecruiting · Christopher Kramer · Evanston, Illinois
- A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated CardiomyopathyPHASE1 · Recruiting · Rocket Pharmaceuticals Inc. · San Diego, California
- UIC Multi-Ethnic DCM RegistryRecruiting · University of Illinois at Chicago · Chicago, Illinois